Case Record of the Massachusetts General Hospital (@MassGeneralNews): A 32-Year-Old Woman with Fatigue and Myalgias #DermTwitter #Cardiology

A 71-year-old man presented with a 2-year history of a gradually darkening line on his left thumbnail. What is the most likely diagnosis?

Join millions who have switched to Grok.

RT @JWatch: Among patients with bubonic plague in Madagascar, ciprofloxacin alone was comparable to aminoglycosides followed by ciprofloxac….

Can culinary medicine be sustainably integrated into clinical care? . Integrating evidence-based nutrition into clinical care is an emerging strategy to address the burden of chronic disease. Yet access remains limited due to time, expertise, and reimbursement challenges. To

RT @NEJM_AI: Volume 2, No. 9 of NEJM AI is now available! Here is a preview of the latest content: . 𝗘𝗱𝗶𝘁𝗼𝗿𝗶𝗮𝗹𝘀 .AI-Enabled Video Biomechan….

In high-risk cutaneous squamous-cell carcinoma, adjuvant cemiplimab prolonged disease-free survival and reduced recurrence risk as compared with placebo. No new safety concerns with cemiplimab were seen. Full C-POST phase 3 trial results and Research Summary:

A rare T-cell lymphoma after chimeric antigen receptor (CAR) T-cell therapy for myeloma was linked to CCR4 overexpression and vector integration, which highlights the need for monitoring after CAR T-cell therapy. Read the full case details:

Despite their limited experience, medical students and residents are often sought out for health advice by family and friends. In an inequitable health system, these consults may seem essential. Read the Perspective essay by Tessa Adzemovic, MD:

Bitcoin’s on fire at $112K! Time to flip the charts on BTCC!.Exploring Cryptocurrency with Jaren Jackson Jr.🏀.

A man with heart failure presented with 2 weeks of shortness of breath. The jugular venous pressure was seen at the angle of the jaw and increased for more than 10 seconds when pressure was applied to the abdomen (shown in a video). Read the full case details in the Images in

The authors of a new Perspective write that the FDA has begun soliciting feedback to inform the next version of the Prescription Drug User Fee Act. User fees remain critical for supporting regulatory operations, but the program’s future is unclear. Read the full Perspective:

The authors of a new Review Article, the latest in the Medical Education series, propose a framework that leverages educational strategies to teach and assess critical thinking during clinical supervision of trainees wherever AI is being used. Read the full review:

RT @nejmcatalyst: 📢📝 Call for Papers: AI Implementation in Care Delivery⁣

Science behind the Study: GM-CSF in Autoimmune Pulmonary Alveolar Proteinosis . #Pulmonology #Genetics

In the IMPALA-2 phase 3 trial, the inhaled recombinant human GM-CSF molgramostim improved pulmonary gas transfer in patients with autoimmune pulmonary alveolar proteinosis. Full trial results and Research Summary:

Could a structured exercise program after undergoing adjuvant chemotherapy for colon cancer improve survival and quality of life? . The latest video in our partnership with @DGlaucomflecken summarizes new research. Access the article for free:

Dive into the magic of Disney with my heartfelt cover! As a passionate vocalist, I'm bringing those iconic lyrics to life in a fresh rendition that'll transport you back to your favorite animated world. Perfect for Disney fans, music lovers, & anyone craving some nostalgic vibe

Images in Clinical Medicine: Paraganglioma in the Organ of Zuckerkandl . #Endocrinology #Radiology

Perspective by Thomas C. Tsai, MD, MPH (@Thomasctsai), Gregg S. Meyer, MD, and @DavidBlumenthal, MD, MPP: Regulating Private Equity in Health Care — The Massachusetts Model . #HealthPolicy #MedicalEthics

RT @NEJMEvidence: Volume 4 Issue 9 of 𝘕𝘌𝘑𝘔 𝘌𝘷𝘪𝘥𝘦𝘯𝘤𝘦 is now available! Here is a preview of the latest content:. 𝗢𝗿𝗶𝗴𝗶𝗻𝗮𝗹 𝗔𝗿𝘁𝗶𝗰𝗹𝗲𝘀.Pemigatin….

In the OASIS-4 phase 3 trial involving women taking endocrine therapy for HR-positive breast cancer, elinzanetant (a neurokinin-targeted therapy) significantly reduced the frequency of moderate-to-severe vasomotor symptoms. Full trial results and Research Summary:

From the NEJM Archive: Scleroderma (Progressive Systemic Sclerosis) Associated with Cancer of the Lung — Brief Review and Report of a Case (Original Article, August 30, 1956)